← Back to Search

Behavioral Intervention

AI-Based Lifestyle Recommendations for Hypertension

N/A
Waitlist Available
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up initial 2 week data collection, weekly lifestyle recommendations, 6 months total
Awards & highlights

Summary

In this RCT, up to 100 adults classified as pre-hypertensive will be randomized to either an artificial intelligence (AI) based lifestyle intervention group or an active control group with a 1 to 1 ratio. Both groups will receive an identical activity tracker (Samsung Galaxy Watch) and BP monitor (Omron Evolv). The AI intervention group will receive automated and personalized lifestyle recommendations based on their lifestyle (e.g. sleep, exercise and diet) and blood pressure (BP) data, involving an automated analytics engine using statistics and machine learning. The active control group will not receive these lifestyle recommendations. The investigators aim to assess objectively the effectiveness of the AI-based personalized lifestyle recommendations on the patients BP.

Eligible Conditions
  • Hypertension

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~initial 2 week data collection, weekly lifestyle recommendations, 6 months total
This trial's timeline: 3 weeks for screening, Varies for treatment, and initial 2 week data collection, weekly lifestyle recommendations, 6 months total for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Average change in diastolic blood pressure (DBP) in experimental vs. control group
Average change in systolic blood pressure (SBP) in experimental vs. control group
Secondary study objectives
Number of patients in experimental group that followed lifestyle recommendations

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: AI-Based Lifestyle Recommendations GroupExperimental Treatment1 Intervention
Participants in this group receive AI-based, personalized lifestyle recommendations based on analysis of their activity tracker and blood pressure data.
Group II: Control GroupActive Control1 Intervention
Participants in this group do not receive the lifestyle recommendations, but are provided with an identical activity tracker and blood pressure monitor.

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,157 Previous Clinical Trials
1,571,319 Total Patients Enrolled
24 Trials studying Hypertension
13,313 Patients Enrolled for Hypertension
~20 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top